5:05 PM ET
8-K
Executive Compensation
Actinium Pharmaceuticals Executive Compensation
Actinium Pharmaceuticals appointed Matt David, M.D., as Chief Financial Officer, effective October 14, 2026. Dr. David's compensation package includes a $450,000 base salary, a $150,000 sign-on bonus, and an inducement grant of 250,000 stock options and 325,000 restricted stock units.